|
| Press Releases |
|
 |
|
| Monday, March 30, 2020 |
|
|
中国生物制药公布2019年年度业绩 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2019年12月31日止年度（「年度」）之财务业绩。 more info >> |
|
|
中國生物製藥公佈2019年年度業績 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2019年12月31日止年度（「年度」）之財務業績。 more info >> |
|
|
Sino Biopharm Announces 2019 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
| Tuesday, January 21, 2020 |
|
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
| Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
| Tuesday, November 26, 2019 |
|
|
中国生物制药公布2019年第三季度业绩 |
| 中国领先的创新驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2019年9月30日止九个月（「回顾期」）之未经审核财务业绩。 more info >> |
|
|
中國生物製藥公佈2019年第三季度業績 |
| 中國領先的創新驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2019年9月30日止九個月（「回顧期」）之未經審核財務業績。 more info >> |
|
|
Sino Biopharmaceutical Announces 2019 Third Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited third quarterly results for the nine months ended 30 September 2019 ("the review period"). more info >> |
|
| Thursday, August 29, 2019 |
|
|
中国生物制药公布2019年中期业绩 |
中国领先的创新驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）今天公布截至2019年6月30日止六个月（「回顾期」）之未经审核财务业绩。
more info >> |
|
|
中國生物製藥公佈2019年中期業績 |
中國領先的創新驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）今天公佈截至2019年6月30日止六個月（「回顧期」）之未經審核財務業績。
more info >> |
|
|
Sino Biopharmaceutical Announces 2019 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced today its unaudited interim results for the six months ended 30 June 2019 (the "review period").
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Fujitsu, ANA X, Toshiba Data, and Kawasaki City launch Japan's first pilot program to quantify citizen CO2 reduction
Feb 25, 2025 11:24 JST
|
|
|
蜜雪集團招股中：揚帆「出海」 東南亞成全球化橋頭堡
Feb 25, 2025 10:11 HKT/SGT
|
|
|
蜜雪集团招股中：扬帆「出海」 东南亚成全球化桥头堡
Feb 25, 2025 10:07 HKT/SGT
|
|
|
富士通、ANA X、東芝データ、川崎市、市民の環境行動によるCO2削減量を環境省のデータベースを用いて可視化する国内初の実証実験を開始
Feb 25, 2025 10:00: JST
|
|
|
2025年第十一屆投資者關係大獎現正接受公眾提名
Feb 25, 2025 09:17 HKT/SGT
|
|
|
數字化及全球化打造行業領導力 全球現製飲品龍頭蜜雪集團招股中
Feb 25, 2025 09:11 HKT/SGT
|
|
|
旅遊嘉年華「香港旅遊博覽會2025」圓滿落幕
Feb 25, 2025 09:04 HKT/SGT
|
|
|
HKIRA 11th IR Awards 2025 now open for nomination
Feb 25, 2025 08:53 HKT/SGT
|
|
|
"Hong Kong Holiday & Travel Expo 2025" Successfully Concludes
Feb 25, 2025 08:49 HKT/SGT
|
|
|
GMG Unveils G(R) Lubricant Engine Performance Testing Results: A Transformative Graphene Energy Saving Solution for the Multi Trillion Dollar Global Liquid Fuel Industry
Feb 24, 2025 21:59 HKT/SGT
|
|
|
CALB (3931.HK) Announced a Positive Profit Alert
Feb 24, 2025 20:32 HKT/SGT
|
|
|
中創新航發佈盈喜 預期2024全年獲淨利潤同比上升約80%至100%
Feb 24, 2025 20:30 HKT/SGT
|
|
|
中创新航发布盈喜 预期2024全年获净利润同比上升约80%至100%
Feb 24, 2025 20:26 HKT/SGT
|
|
|
Hong Kong rated as leading sustainable business hub
Feb 24, 2025 18:13 HKT/SGT
|
|
|
Blackrock Silver Steps Out and Hits Multiple +1 kg/t AgEq Intercepts in First Assays from Resource Expansion Program at Tonopah West
Feb 24, 2025 18:09 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
